{
    "id": "correct_subsidiary_00053_1",
    "rank": 73,
    "data": {
        "url": "https://www.grandviewresearch.com/industry-analysis/personalized-medicine-market",
        "read_more_link": "",
        "language": "en",
        "title": "Personalized Medicine Market Size And Share Report, 2030",
        "top_image": "https://www.grandviewresearch.com/static/img/research/global-personalized-medicine-market-size.png",
        "meta_img": "https://www.grandviewresearch.com/static/img/research/global-personalized-medicine-market-size.png",
        "images": [
            "https://www.grandviewresearch.com/static/img/cover-new-3.png",
            "https://www.grandviewresearch.com/static/img/research/global-personalized-medicine-market-size.png",
            "https://www.grandviewresearch.com/static/img/research/personalized-medicine-market-concentration-characteristics.png",
            "https://www.grandviewresearch.com/static/img/research/global-personalized-medicine-market.png",
            "https://www.grandviewresearch.com/static/img/research/personalized-medicine-market-trends-by-region.png",
            "https://www.grandviewresearch.com/static/img/research/global-personalized-medicine-market-report-segmentation.png",
            "https://www.grandviewresearch.com/static/img/key-2030.png?v=6.5.2",
            "https://www.grandviewresearch.com/static/img/pdf_1.svg",
            "https://www.grandviewresearch.com/static/img/arrow_report.svg",
            "https://www.grandviewresearch.com/static/img/customize-setting-icon.png",
            "https://www.grandviewresearch.com/static/img/certified_logos-min.png",
            "https://www.grandviewresearch.com/static/img/iso_icn.png",
            "https://www.grandviewresearch.com/static/img/report-showing-img-large.jpg",
            "https://www.grandviewresearch.com/static/img/report-showing-img-1.jpg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "Personalized Medicine Market - Global Personalized Medicine Industry Size",
            "Share",
            "Analysis And Research Report"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "The global personalized medicine market was valued at USD 529.28 billion in 2023 and is projected to grow at a CAGR of 8.20% from 2024 to 2030.",
        "meta_lang": "en",
        "meta_favicon": "/favicon.ico",
        "meta_site_name": "",
        "canonical_link": "https://www.grandviewresearch.com/industry-analysis/personalized-medicine-market",
        "text": "Table of Contents\n\nChapter 1. Methodology and Scope\n\n1.1. Market Segmentation & Scope\n\n1.2. Segment Definitions\n\n1.2.1. Product\n\n1.2.2. End-use\n\n1.2.3. Regional scope\n\n1.2.4. Estimates and forecasts timeline\n\n1.3. Research Methodology\n\n1.4. Information Procurement\n\n1.4.1. Purchased database\n\n1.4.2. GVR’s internal database\n\n1.4.3. Secondary sources\n\n1.4.4. Primary research\n\n1.4.5. Details of primary research\n\n1.4.5.1. Data for primary interviews in North America\n\n1.4.5.2. Data for primary interviews in Europe\n\n1.4.5.3. Data for primary interviews in Asia Pacific\n\n1.4.5.4. Data for primary interviews in Latin America\n\n1.4.5.5. Data for Primary interviews in MEA\n\n1.5. Information or Data Analysis\n\n1.5.1. Data analysis models\n\n1.6. Market Formulation & Validation\n\n1.7. Model Details\n\n1.7.1. Commodity flow analysis (Model 1)\n\n1.7.2. Approach 1: Commodity flow approach\n\n1.7.3. Volume price analysis (Model 2)\n\n1.7.4. Approach 2: Volume price analysis\n\n1.8. List of Secondary Sources\n\n1.9. List of Primary Sources\n\n1.10. Objectives\n\nChapter 2. Executive Summary\n\n2.1. Market Outlook\n\n2.2. Segment Outlook\n\n2.2.1. Product outlook\n\n2.2.2. End-use outlook\n\n2.2.3. Regional outlook\n\n2.3. Competitive Insights\n\nChapter 3. Personalized Medicine Market Variables, Trends & Scope\n\n3.1. Market Lineage Outlook\n\n3.1.1. Parent market outlook\n\n3.1.2. Related/ancillary market outlook\n\n3.2. Market Dynamics\n\n3.2.1. Market driver analysis\n\n3.2.1.1. Advancements in next-generation sequencing technology\n\n3.2.1.2. Expanding portfolio of companion/associated diagnostics\n\n3.2.1.3. Increasing prevalence of cancer & usage of biomarkers for personalized medicine cancer therapy\n\n3.2.1.4. Technological advancements to facilitate R&D for personalized medicine\n\n3.2.2. Market restraint analysis\n\n3.2.2.1. Presence of nonvalue-based personalized medicine diagnostics reimbursement policy\n\n3.2.2.2. Lack of proper intellectual property regulations for personalized medical technologies\n\n3.3. Personalized Medicine Market Analysis Tools\n\n3.3.1. Industry Analysis - Porter’s\n\n3.3.1.1. Supplier power\n\n3.3.1.2. Buyer power\n\n3.3.1.3. Substitution threat\n\n3.3.1.4. Threat of new entrant\n\n3.3.1.5. Competitive rivalry\n\n3.3.2. PESTEL Analysis\n\n3.3.2.1. Political landscape\n\n3.3.2.2. Technological landscape\n\n3.3.2.3. Economic landscape\n\nChapter 4. Personalized Medicine Market: Product Estimates & Trend Analysis\n\n4.1. Product Market Share, 2023 & 2030\n\n4.2. Segment Dashboard\n\n4.3. Global Personalized Medicine Market by Product Outlook\n\n4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following\n\n4.4.1. Personalized Medicine Diagnostics\n\n4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n4.4.1.2. Genetic Testing\n\n4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n4.4.1.3. DTC Diagnostics\n\n4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n4.4.1.4. Esoteric Lab Services\n\n4.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n4.4.1.5. Esoteric Lab Tests\n\n4.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n4.4.2. Personalized Medicine Therapeutics\n\n4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n4.4.2.2. Pharmaceutical\n\n4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n4.4.2.3. Genomic Medicine\n\n4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n4.4.2.4. Medical Devices\n\n4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n4.4.3. Personalized Medical Care\n\n4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n4.4.3.2. Telemedicine\n\n4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n4.4.3.3. Health Information Technology\n\n4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n4.4.4. Personalized Nutrition & Wellness\n\n4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n4.4.4.2. Retail Nutrition\n\n4.4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n4.4.4.3. Complementary & Alternative Medicine\n\n4.4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\nChapter 5. Personalized Medicine Market: End-use Estimates & Trend Analysis\n\n5.1. Method Market Share, 2023 & 2030\n\n5.2. Segment Dashboard\n\n5.3. Global Personalized Medicine Market by End-use Outlook\n\n5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following\n\n5.4.1. Hospitals\n\n5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n5.4.2. Academic & Research Institutes\n\n5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n5.4.3. Diagnostic Centers\n\n5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\n5.4.4. Others\n\n5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)\n\nChapter 6. Personalized Medicine Market: Regional Estimates & Trend Analysis\n\n6.1. Regional Market Share Analysis, 2023 & 2030\n\n6.2. Regional Market Dashboard\n\n6.3. Global Regional Market Snapshot\n\n6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:\n\n6.5. North America\n\n6.5.1. U.S.\n\n6.5.1.1. Key country dynamics\n\n6.5.1.2. Regulatory framework/ reimbursement structure\n\n6.5.1.3. Competitive scenario\n\n6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.5.2. Canada\n\n6.5.2.1. Key country dynamics\n\n6.5.2.2. Regulatory framework/ reimbursement structure\n\n6.5.2.3. Competitive scenario\n\n6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.6. Europe\n\n6.6.1. UK\n\n6.6.1.1. Key country dynamics\n\n6.6.1.2. Regulatory framework/ reimbursement structure\n\n6.6.1.3. Competitive scenario\n\n6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.6.2. Germany\n\n6.6.2.1. Key country dynamics\n\n6.6.2.2. Regulatory framework/ reimbursement structure\n\n6.6.2.3. Competitive scenario\n\n6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.6.3. France\n\n6.6.3.1. Key country dynamics\n\n6.6.3.2. Regulatory framework/ reimbursement structure\n\n6.6.3.3. Competitive scenario\n\n6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.6.4. Italy\n\n6.6.4.1. Key country dynamics\n\n6.6.4.2. Regulatory framework/ reimbursement structure\n\n6.6.4.3. Competitive scenario\n\n6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.6.5. Spain\n\n6.6.5.1. Key country dynamics\n\n6.6.5.2. Regulatory framework/ reimbursement structure\n\n6.6.5.3. Competitive scenario\n\n6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.6.6. Norway\n\n6.6.6.1. Key country dynamics\n\n6.6.6.2. Regulatory framework/ reimbursement structure\n\n6.6.6.3. Competitive scenario\n\n6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.6.7. Sweden\n\n6.6.7.1. Key country dynamics\n\n6.6.7.2. Regulatory framework/ reimbursement structure\n\n6.6.7.3. Competitive scenario\n\n6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.6.8. Denmark\n\n6.6.8.1. Key country dynamics\n\n6.6.8.2. Regulatory framework/ reimbursement structure\n\n6.6.8.3. Competitive scenario\n\n6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.7. Asia Pacific\n\n6.7.1. Japan\n\n6.7.1.1. Key country dynamics\n\n6.7.1.2. Regulatory framework/ reimbursement structure\n\n6.7.1.3. Competitive scenario\n\n6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.7.2. China\n\n6.7.2.1. Key country dynamics\n\n6.7.2.2. Regulatory framework/ reimbursement structure\n\n6.7.2.3. Competitive scenario\n\n6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.7.3. India\n\n6.7.3.1. Key country dynamics\n\n6.7.3.2. Regulatory framework/ reimbursement structure\n\n6.7.3.3. Competitive scenario\n\n6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.7.4. Australia\n\n6.7.4.1. Key country dynamics\n\n6.7.4.2. Regulatory framework/ reimbursement structure\n\n6.7.4.3. Competitive scenario\n\n6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.7.5. South Korea\n\n6.7.5.1. Key country dynamics\n\n6.7.5.2. Regulatory framework/ reimbursement structure\n\n6.7.5.3. Competitive scenario\n\n6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.7.6. Thailand\n\n6.7.6.1. Key country dynamics\n\n6.7.6.2. Regulatory framework/ reimbursement structure\n\n6.7.6.3. Competitive scenario\n\n6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.8. Latin America\n\n6.8.1. Brazil\n\n6.8.1.1. Key country dynamics\n\n6.8.1.2. Regulatory framework/ reimbursement structure\n\n6.8.1.3. Competitive scenario\n\n6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.8.2. Mexico\n\n6.8.2.1. Key country dynamics\n\n6.8.2.2. Regulatory framework/ reimbursement structure\n\n6.8.2.3. Competitive scenario\n\n6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.8.3. Argentina\n\n6.8.3.1. Key country dynamics\n\n6.8.3.2. Regulatory framework/ reimbursement structure\n\n6.8.3.3. Competitive scenario\n\n6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.9. MEA\n\n6.9.1. South Africa\n\n6.9.1.1. Key country dynamics\n\n6.9.1.2. Regulatory framework/ reimbursement structure\n\n6.9.1.3. Competitive scenario\n\n6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.9.2. Saudi Arabia\n\n6.9.2.1. Key country dynamics\n\n6.9.2.2. Regulatory framework/ reimbursement structure\n\n6.9.2.3. Competitive scenario\n\n6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.9.3. UAE\n\n6.9.3.1. Key country dynamics\n\n6.9.3.2. Regulatory framework/ reimbursement structure\n\n6.9.3.3. Competitive scenario\n\n6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Billion)\n\n6.9.4. Kuwait\n\n6.9.4.1. Key country dynamics\n\n6.9.4.2. Regulatory framework/ reimbursement structure\n\n6.9.4.3. Competitive scenario\n\n6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Billion)\n\nChapter 7. Competitive Landscape\n\n7.1. Recent Developments & Impact Analysis, By Key Market Participants\n\n7.2. Company/Competition Categorization\n\n7.3. Vendor Landscape\n\n7.3.1. List of key distributors and channel partners\n\n7.3.2. Key customers\n\n7.3.3. Key company market share analysis, 2023\n\n7.3.4. GE Healthcare\n\n7.3.4.1. Overview\n\n7.3.4.2. Financial Performance\n\n7.3.4.3. Product Benchmarking\n\n7.3.4.4. Strategic Initiatives\n\n7.3.5. Illumina, Inc.\n\n7.3.5.1. Overview\n\n7.3.5.2. Financial Performance\n\n7.3.5.3. Product Benchmarking\n\n7.3.5.4. Strategic Initiatives\n\n7.3.6. ASURAGEN, INC.\n\n7.3.6.1. Overview\n\n7.3.6.2. Financial Performance\n\n7.3.6.3. Product Benchmarking\n\n7.3.6.4. Strategic Initiatives\n\n7.3.7. Abbott\n\n7.3.7.1. Overview\n\n7.3.7.2. Financial Performance\n\n7.3.7.3. Product Benchmarking\n\n7.3.7.4. Strategic Initiatives\n\n7.3.8. Dako A/S\n\n7.3.8.1. Overview\n\n7.3.8.2. Financial Performance\n\n7.3.8.3. Product Benchmarking\n\n7.3.8.4. Strategic Initiatives\n\n7.3.9. Exact Sciences Corporation\n\n7.3.9.1. Overview\n\n7.3.9.2. Financial Performance\n\n7.3.9.3. Product Benchmarking\n\n7.3.9.4. Strategic Initiatives\n\n7.3.10. Danaher Corporation (Cepheid, Inc.)\n\n7.3.10.1. Overview\n\n7.3.10.2. Financial Performance\n\n7.3.10.3. Product Benchmarking\n\n7.3.10.4. Strategic Initiatives\n\n7.3.11. Decode Genetics, Inc.\n\n7.3.11.1. Overview\n\n7.3.11.2. Financial Performance\n\n7.3.11.3. Product Benchmarking\n\n7.3.11.4. Strategic Initiatives\n\n7.3.12. QIAGEN\n\n7.3.12.1. Overview\n\n7.3.12.2. Financial Performance\n\n7.3.12.3. Product Benchmarking\n\n7.3.12.4. Strategic Initiatives\n\n7.3.13. Exagen Inc.\n\n7.3.13.1. Overview\n\n7.3.13.2. Financial Performance\n\n7.3.13.3. Product Benchmarking\n\n7.3.13.4. Strategic Initiatives\n\n7.3.14. Precision Biologics\n\n7.3.14.1. Overview\n\n7.3.14.2. Financial Performance\n\n7.3.14.3. Product Benchmarking\n\n7.3.14.4. Strategic Initiatives\n\n7.3.15. Celera Diagnostics LLC\n\n7.3.15.1. Overview\n\n7.3.15.2. Financial Performance\n\n7.3.15.3. Product Benchmarking\n\n7.3.15.4. Strategic Initiatives\n\n7.3.16. Biogen\n\n7.3.16.1. Overview\n\n7.3.16.2. Financial Performance\n\n7.3.16.3. Product Benchmarking\n\n7.3.16.4. Strategic Initiatives\n\n7.3.17. Genelex\n\n7.3.17.1. Overview\n\n7.3.17.2. Financial Performance\n\n7.3.17.3. Product Benchmarking\n\n7.3.17.4. Strategic Initiatives\n\n7.3.18. IBM\n\n7.3.18.1. Overview\n\n7.3.18.2. Financial Performance\n\n7.3.18.3. Product Benchmarking\n\n7.3.18.4. Strategic Initiatives\n\n7.3.19. Genentech, Inc.\n\n7.3.19.1. Overview\n\n7.3.19.2. Financial Performance\n\n7.3.19.3. Product Benchmarking\n\n7.3.19.4. Strategic Initiatives\n\n7.3.20. 23andMe, Inc.\n\n7.3.20.1. Overview\n\n7.3.20.2. Financial Performance\n\n7.3.20.3. Product Benchmarking\n\n7.3.20.4. Strategic Initiatives\n\nList of Tables\n\nTable 1 List of Abbreviation\n\nTable 2 North America Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)\n\nTable 3 North America Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 4 North America Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 5 U.S. Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 6 U.S. Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 7 Canada Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 8 Canada Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 9 Europe Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)\n\nTable 10 Europe Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 11 Europe Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 12 France Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 13 France Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 14 Germany Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 15 Germany Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 16 UK Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 17 UK Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 18 Spain Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 19 Spain Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 20 France Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 21 France Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 22 Italy Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 23 Italy Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 24 Sweden Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 25 Sweden Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 26 Norway Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 27 Norway Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 28 Denmark Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 29 Denmark Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 30 Asia Pacific Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)\n\nTable 31 Asia Pacific Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 32 Asia Pacific Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 33 Japan Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 34 Japan Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 35 China Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 36 China Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 37 India Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 38 India Personalized Medicine Market, By End-Use, 2018 - 2030 (USD Billion)\n\nTable 39 South Korea Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 40 South Korea Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 41 Australia Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 42 Australia Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 43 Thailand Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 44 Thailand Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 45 Latin America Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)\n\nTable 46 Latin America Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 47 Latin America Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 48 Brazil Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 49 Brazil Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 50 Mexico Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 51 Mexico Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 52 Argentina Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 53 Argentina Personalized Medicine Market, By End-Use, 2018 - 2030 (USD Billion)\n\nTable 54 MEA Personalized Medicine Market, By Country, 2018 - 2030 (USD Billion)\n\nTable 55 MEA Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 56 MEA Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 57 South Africa Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 58 South Africa Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 59 Saudi Arabia Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 60 Saudi Arabia Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 61 UAE Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 62 UAE Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nTable 63 Kuwait Personalized Medicine Market, By Product, 2018 - 2030 (USD Billion)\n\nTable 64 Kuwait Personalized Medicine Market, By End-use, 2018 - 2030 (USD Billion)\n\nList of Figures"
    }
}